Nucleus RNA binding protein RNA processing Matrin 3 PSF Rev a b s t r a c t Human immunodeficiency virus gene expression and replication are regulated at several levels. Incompletely spliced viral RNAs and full-length genomic RNA contain the RRE element and are bound by the viral trans-acting protein Rev to be transported out of the nucleus. Previously we found that the nuclear matrix protein MATR3 was a cofactor of Rev-mediated RNA export. Here we show that the pleiotropic protein PSF binds viral RNA and is associated with MATR3. PSF is involved in the maintenance of a pool of RNA available for Rev activity. However, while Rev and PSF bind the viral pre-mRNA at the site of viral transcription, MATR3 interacts at a subsequent step. We propose that PSF and MATR3 define a novel pathway for RRE-containing HIV-1 RNAs that is hijacked by the viral Rev protein.
Introduction
Human immunodeficiency virus type 1 (HIV-1) gene expression and replication are regulated at the transcriptional and posttranscriptional level. The generation of infectious viral progeny requires the synthesis and export to the cytoplasm of several fully spliced subgenomic mRNAs encoding for regulatory factors that include the Tat transactivator and Rev (Greene and Peterlin, 2002) . Rev promotes the expression of Gag, Pol and Env incompletely spliced viral RNAs and full-length genomic RNAs (Malim et al., 1989; Sodroski et al., 1986) reviewed in: Kula and Marcello (2012) , Pollard and Malim (1998) , Yedavalli and Jeang (2011b) . Rev promotes the export of this class of RNAs from the nucleus through the association with an RNA element called the Rev response element (RRE) that is present in the env gene (Chang and Sharp, 1989; Kjems et al., 1991; Zapp and Green, 1989) . HIV-1 exploits a variety of mechanisms to make sure that all required RNAs are balanced for an efficient life cycle (Purcell and Martin, 1993; Schwartz et al., 1990) . Sub-optimal splice acceptor sequences and the activity of splicing regulators reduce HIV-1 pre-mRNA splicing rates (Amendt et al., 1994 (Amendt et al., , 1995 Caputi et al., 1999; Dyhr-Mikkelsen and Kjems, 1995; O'Reilly et al., 1995; Si et al., 1997; Cochrane, 1994, 1995; Tange et al., 2001) . This mechanism is believed to permit the production of both fully spliced mRNAs as well as RRE-containing RNAs. HIV-1 also encodes for regulatory sequences called the instability (INS) sequences (Cochrane et al., 1991; Maldarelli et al., 1991; Nasioulas et al., 1994; Schneider et al., 1997; Schwartz et al., 1992) . One possible role for these elements is to ensure that incompletely spliced pre-mRNAs are not simply degraded in the nucleus prior to export to the cytoplasm by preserving the RNA in nuclear sub-compartments (Berthold and Maldarelli, 1996; Chang and Sharp, 1989; Mikaelian et al., 1996) . Hence, a combination of cis-acting RNA sequences with a trans-acting viral protein (Rev) together with host factors concur to regulate HIV-1 gene expression and replication.
The molecular details of Rev binding to RRE as well as the mechanism of Rev-mediated RNA export by Exportin 1 (CRM1) have been described in detail (Daugherty et al., 2010; Fornerod et al., 1997; Kjems et al., 1991; Malim and Cullen, 1991) . However, much less is known of the nuclear steps that occur between pre-mRNA biogenesis, Rev recognition and nuclear export. To address this issue we have recently initiated an unbiased program of discovery of nuclear factors that associated with HIV-1 RNA (Kula et al., 2011) . Among them Matrin 3 (MATR3) was found to be specifically associated with the viral RNA, as confirmed also by other groups (Naji et al., 2011; Yedavalli and Jeang, 2011a) . MATR3 had no effect on transcription from the HIV-1 LTR but promoted the Rev-dependent cytoplasmic accumulation and consequent translation of RRE-containing unspliced RNAs (Kula et al., 2011; Yedavalli and Jeang, 2011a) . MATR3 is a RNA binding protein and a component of the inner nuclear matrix (Belgrader et al., 1991; Hibino et al., 2006; Nakayasu and Berezney, 1991; Zeitz et al., 2009) . Together with the cellular protein polypyrimidine tract-binding protein associated binding factor PSF (also known as splicing factor Proline-Glutamine Rich, SFPQ), MATR3 has been implicated in the nuclear retention of hyperedited mRNA (Prasanth et al., 2005; Zhang and Carmichael, 2001) . PSF is a multifunctional nuclear protein that has been involved in a variety of processes in addition to nuclear retention of hyperedited RNA including splicing and transcription (Emili et al., 2002; Kaneko et al., 2007; Shav-Tal and Zipori, 2002) . PSF has also been shown to bind specifically to HIV-1 INS elements (Zolotukhin et al., 2003) . PSF was also found associated with HIV-1 RNA in the nucleus but it's role in HIV-1 gene expression remained unknown (Kula et al., 2011) .
In this work we investigated the role of PSF in Rev-mediated RNA export and its relationship with MATR3. We found that PSF is not involved in LTR-mediated transcription but is required for Rev activity independent of A to I hyperediting of HIV-1 RNA. PSF and MATR3 interacted at the protein level while their interaction with Rev occurred only through RNA. PSF and Rev associated with nascent pre-mRNA at the HIV-1 transcription site while MATR3 bound viral unspliced RNA in the insoluble nuclear matrix. Since PSF was shown to bind the INS elements (Zolotukhin et al., 2003) and MATR3 was shown to promote Rev-mediated export of unspliced RNA (Kula et al., 2011) , we propose that HIV-1 unspliced RRE-containing HIV-1 RNAs are committed to MATR3/Rev mediated export by PSF. Fig. 1 . PSF binds HIV-1 RNA and acts at the post-transcriptional level. (A) Pulldown of HIV-1 RNA and endogenous PSF. Whole cell extracts from mock cells (U2OS_wt), U2OS_HIVexo, U2OS_HIVintro or U2OS_CMV24xMS2 expressing Flag-MS2nls and Tat were immunoprecipitated with anti-flag antibody. Immunoblot analysis was then performed to detect the RNA-bound endogenous PSF (IP). Immunoblots for the whole cell extracts against PSF and flag-MS2nls (input) are also shown. (B) PSF knockdown leads to a decrease of Gag expression. HeLa cells were transfected with the siRNA targeting PSF (siPSF) or with a control siRNA (siCTRL). After 48 h siRNA-transfected cells were co-transfected with pNL4.3R-E-luc and harvested 24 h later for immunobloting. Tubulin is the protein loading control. (C) PSF knockdown does not affect the luciferase activity. HeLa cells were transfected with the indicated siRNAs. After 48 h siRNA-transfected cells were co-transfected with pCMV-Renilla together with the pNL4.3R-E-luc HIV molecular clone and harvested 24 h later for luciferase assays. Relative Luc/RL expression was normalized to protein levels measured by Bradford assay. The results of three independent experiments are shown 7SD.
Results
Identification of PSF as a factor required for post-transcriptional expression of gag mRNA Previously, to identify cellular HIV-1 RNA binding factors, we developed a novel proteomic approach based on the MS2 tagging system (Maiuri et al., 2011a) . Briefly, we used stable cells lines with an integrated viral vector expressing viral RNA tagged with MS2binding sites and we affinity purified RNA and associated proteins by flag-MS2 pull down (Kula et al., 2011) . Mass spectrometry analysis revealed several cellular factors as potential viral RNA regulators. In this screen we identified both MATR3 and PSF. We and others identified MATR3 as a nuclear factor that stimulates the Rev-dependent cytoplasmic accumulation and translation of RRE-containing unspliced RNAs (Kula et al., 2011; Yedavalli, 2011) . Since PSF binds MATR3 and HIV-1 RNA we wished to explore its activity in HIV-1 gene expression.
To confirm that PSF specifically co-immunoprecipitates with viral RNA we transfected the U2OS_HIVexo and U2OS_HIVintro stable cell lines carrying the MS2-tagged HIV construct with flag-MS2nls and Tat, the viral trans-activator that allows transcription of the viral genes (Marcello et al., 2001) . As negative controls we used U2OS wild type and U2OS carrying an integrated CMVdriven construct expressing RNA with the same number of MS2 repeats after an unrelated intron (U2OS_CMV24 Â MS2). Cells were lysed and the resulting cell extract was subjected to immunoprecipitation with anti-flag antibodies. Resulting pulldowns were immunoblotted with PSF and flag antibodies. As shown in Fig. 1A , PSF was substantially enriched in flag-MS2 pulldowns in cells expressing HIV-1 RNA compared to control cells confirming that PSF interacts specifically with HIV-1 RNA.
To investigate the functional role of PSF in HIV-1 replication, we measured the effect of RNAi-mediated PSF knockdown on a full-length HIV-1 molecular clone carrying the luciferase reporter gene in nef (pNL4.3R-E-luc). As shown in Fig. 1B , upon PSF depletion we observed that gag expression, which is dependent on Rev-mediated export of RRE containing RNAs, was reduced. Conversely, the luciferase activity, which depends on the Revindependent nef transcript, was not affected (Fig. 1C) . These findings suggest that PSF is involved in Rev-mediated export of RRE containing RNAs rather than transcription.
PSF impacts on Rev activity in the nucleus
In order to confirm if PSF affects Rev activity we knocked down PSF by siRNAs and looked at the viral RNA expressed from the HIV-1 derived vector vHY-IRES-TK (Marcello and Giaretta, 1998) . This vector, that we extensively used to characterize MATR3 function, is Tat and Rev responsive and expresses a portion of the Gag protein (p17 n ) that can be detected by immunoblot (Kula et al., 2011) . As shown in Fig. 2A , efficient knockdown of PSF was obtained in the presence and absence of Rev. Next we examined the levels of unspliced viral RNA by RT-PCR. As shown in the Fig. 2B , in the presence of Rev, the level of unspliced viral RNA is increased due to Rev activity (compare lane 3 and 4). Interestingly, the Rev-mediated increase of unspliced HIV-1 pre-mRNA over spliced RNA was less evident when PSF was depleted (Fig. 2B, compare lanes 1 and 2) . Quantitative real-time RT-PCR (qRT-PCR) confirmed that, while depletion of PSF did not affect the steady-state levels of unspliced RNAs, it strongly affected its Rev-mediated increase (Fig. 2C ). Furthermore, we demonstrated that the level of p17 protein, which is a product of the truncated gag gene expressed from unspliced Rev-dependent transcripts of vHY-IRES-TK, was impaired upon PSF depletion (Fig. 2D ). These findings demonstrate that PSF impacts on viral unspliced RNA and Rev-activity. However, PSF could act either by modulating the levels of viral RNA in the nucleus or by affecting Rev-mediated nuclear export. To address this point we fractionated the cells and measured the levels of viral transcripts in the nucleus and in the cytoplasm. As shown in Fig. 3A , the levels of both the nuclear and the cytoplasmic unspliced HIV-1 RNAs significantly decreased when PSF was depleted. To the contrary, the nuclear and the cytoplasmic Rev-independent spliced HIV-1 RNA did not differ fold changes, whereby siCTRL 293T treated cells transfected with were set as 1. The results of three independent experiments are shown 7SD. The inhibitions were significant (p o 0.01 for both cases). (B) Quantitative analysis of spliced HIV-1 RNA levels modulated by PSF in the nucleus and the cytoplasm. The experiment was conducted for spliced (S) HIV-1 RNA as described above A. No significant decrease was observed (p40.05 for both cases). (C) Control of nuclear and cytoplasmic fractionation and siRNA-mediated knockdown of PSF. A typical western blot of duplicate protein extracts from the nuclear or the cytoplasmic fraction of the siRNA-treated 293T cells used in (A and B) is shown. Tubulin was detected only in the cytoplasmic fractions while PSF was detected only in the nucleus of control siRNA-treated cells (siCTRL) and was depleted from nuclear extracts of cells treated with the siRNA against PSF (siPSF). significantly (Fig. 3B ). To check for the quality of nuclear and cytoplasmic fractionation and RNAi mediated knockdown of PSF a routine immunoblot was performed for Tubulin and PSF itself as shown in Fig. 3C .
Previously by a similar approach it was found that MATR3 impacts selectively on the cytoplasmic levels of unspliced viral RNA pointing to the involvement at the step of Revmediated export (Kula et al., 2011; Yedavalli and Jeang, 2011a) .
Here instead we observed that PSF impacts on both pools of Revdependent transcripts (Fig. 3A) . This result is consistent with the interpretation that PSF may be involved in maintaining the levels of nuclear unspliced viral RNA upstream of the activity of MATR3 and Rev.
Association of PSF with MATR3, Rev and viral RNA
Since both PSF and MATR3 bind viral RNA and were shown to form a complex by others we wished to explore their reciprocal interactions in the presence of Rev. To this end we immunoprecipitated GFP-tagged MATR3 and PSF as shown in Fig. 4A . We found that MATR3 and PSF interact both in the presence and absence of the Rev protein. This observation was confirmed by pulling down the endogenous MATR3 that we found associated with PSF ( Fig. 4B ). Moreover we observed that PSF interacts with MATR3 in an RNA independent manner being resistant to nuclease treatment as shown in Fig. 4B . We can conclude that MATR3 and PSF form a complex through a protein-protein interaction.
Next we asked whether the Rev protein could interact with PSF. To answer this question we set to immunoprecipitate PSF and we found that it binds Rev through RNA since less Rev could be observed in the presence of nuclease treatment (Fig. 4C ). We can conclude that the interaction of PSF with the viral Rev protein is RNA-mediated as it has been previously observed for MATR3 (Kula et al., 2011; Yedavalli and Jeang, 2011a) . PSF and MATR3 have been shown to be part of a complex that retain hyperedited dsRNA in the nucleus (Zhang and Fig. 4 . Association of PSF with MATR3 and Rev. (A) Immunoprecipitation (IP) of GFP-tagged MATR3 and PSF. Whole cell lysates from 293T cells expressing vHY-IRES-TK, Tat and the various GFP-constructs (GFP is a negative control) with or without Rev were subjected to IP with anti-GFP antibodies and proteins were detected by western blotting. (B) MATR3 co-immunoprecipitation with PSF does not require RNA. Whole cell lysates from 293T cells expressing vHY-IRES-TK and Tat were subjected to IP with either anti-MATR3 antibodies or with anti-IgG (mock) and the proteins were detected by Western blot. PSF could be detected on IPs and the interaction persisted after nuclease treatment. (C) PSF co-immunoprecipitation with Rev requires nucleic acid. Whole cell lysates from 293T cells expressing vHY-IRES-TK, Tat, and Rev-GFP were subjected to IP with anti-PSF antibodies or with anti-IgG (mock). The IP were subjected to treatment with nuclease and the proteins were detected by western blotting. Carmichael, 2001) . However, we could not find evidence of substantial A to I hyperediting of HIV-1 RNA (see SI Results and Table S2 ). Hence, the involvement of MATR3 and PSF in nuclear retention of unspliced HIV-1 RNA and Rev activity is independent of hyperediting.
Sub-nuclear distribution of PSF, MATR3, Rev and the HIV-1 transcription site
A great advantage of the MS2-tagging method for RNA visualization is that it discriminates between factors that are associating with nascent RNA or involved at later stages of RNA processing. For example, RNA polymerase II, Tat, CDK9 and Cyclin T1 were all previously found at the site of HIV-1 active transcription, as expected De Marco et al., 2008 Maiuri et al., 2011b; Molle et al., 2007) . In order to explore the localization of PSF we exploited a GFP-tagged version of the protein that was expressed in U2OS HIVintro or U2OS HIVexo together with Tat and Cherry-MS2nls. Both factors were found spatially associated with HIV-1 transcription (Fig. 5A, rows a  and b ). PSF also localized to sub-nuclear structures consistent with paraspeckles, a site of PSF accumulation already described ( Fig. S2A) (Prasanth et al., 2005; Sasaki et al., 2009 ). However, unspliced HIV-1 RNA co-localized with PSF only at the site of transcription and not in paraspeckles (Fig. S2B ). Also endogenous PSF co-localized with the HIV-1 transcription site, ruling out overexpression artifacts (Fig. 5A rows d and e ). A control cell line carrying an integrated CMV-driven construct expressing RNA with the same MS2 repeats (U2OS_CMV24 Â MS2) did not show any co-localization with PSF, pointing to a specific role of these factors in HIV-1 RNA processing (Fig. 5A row c) .
Next we explored the localization of MATR3. GFP-tagged MATR3 showed a nuclear localization with a punctuate appearance, but was never found associated with nascent HIV-1 RNA (Fig. 5B, rows a and b) . The same was true using an antibody against the endogenous MATR3 protein (Fig. 5B rows c and d) .
Finally we investigated the localization of Rev using a Rev-EGFP construct that was shown to be functional in U2OS and HeLa cells ( Supplementary Fig. S3A and B, respectively) . Rev is a shuttling protein that appears predominantly nuclear at steady state in HeLa cells ( Supplementary Fig. S3C ) and predominantly cytoplasmic and nucleolar in U2OS cells (Fig. 5C ). Interestingly, Rev was found associated with the site of HIV-1 transcription in both cell lines (Fig. 5C, rows a and b; Supplementary Fig. S3C ). In other terms, unspliced RRE-containing HIV-1 RNA is available for Rev-mediated export at the site of transcription.
Collectively, these data indicate that PSF and Rev bind nascent viral transcripts at the site of HIV-1 transcription while MATR3 associates with viral RNA once the RNA is released from the site of transcription.
Sub-nuclear fractionation of PSF, MATR3 and Rev
In order to explore further the sub-nuclear distribution of proteins and RNA we established a protocol to separate nuclear soluble and insoluble fractions after digestion with DNase ( Supplementary Fig. S4 ). As shown in Fig. 6A panels a and b respectively, MATR3 behaves like a typical matrix protein whereas PSF is found in both the insoluble (P2) and soluble (S2) fractions similar to chromatin-bound proteins like histones ( Fig. 6A, panel i) . Rev instead is found in the cytoplasm (S1) and in the soluble nuclear fraction (S2), but much less in the insoluble nuclear fraction (P2) (Fig. 6A, panel c) . When we explored the localization of unspliced HIV RNA we found it associated with the insoluble fraction (Fig. 6B, top panels) . Rev induced its appearance in the soluble nuclear fraction as well as in the cytoplasm (Fig. 6B , top panels) in agreement with the production of p17 (Fig. 6A,   panel d) . Control b-actin RNA was found in the insoluble fraction, as well as in the nucleoplasm and the cytoplasm, both with or without Rev (Fig. 6B, bottom panels) .
The insoluble fraction is rather heterogeneous and includes matrix components, like lamins (Fig. 6A, panel f) , as well as elongating RNAPII (Fig. 6A , panels g and h) (Mortillaro et al., 1996) . Therefore, we reasoned that spatially and functionally defined compartments are present in the nuclear insoluble fraction but we could not distinguish them with the current protocol. In order to distinguish the MATR3 compartment from the rest of the insoluble fraction we set to immunoprecipitate HIV-1 RNA using GFP-tagged proteins. As control for the immunoprecipitation we used Lamin A that is present in the insoluble fraction ( Fig. 6A panel f) , but may not be involved in HIV-1 RNA processing. As shown in Fig. 7A , GFP-PSF, MATR3-GFP and control LaminA-GFP could be immunoprecipitated from the P2 fraction both in the presence or absence of Rev. Unspliced HIV RNA remains associated only with MATR3-GFP and not with GFP-tagged Lamin A or PSF (Fig. 7B, compare with pulldown of the irrelevant b-actin RNA). We conclude that unspliced HIV-1 pre-mRNA is found associated with MATR3 in the insoluble nuclear matrix. Interestingly, Rev expression did not deplete RNA from MATR3 pointing to the maintenance of the MATR3 pathway also in the presence of Rev.
Discussion
Once integrated into chromatin, the HIV-1 provirus occupies a spatially defined position within the nucleus (Dieudonne et al., 2009; Marcello et al., 2010) . The single pre-mRNA that is transcribed at this site generates several species of mRNAs and the viral genome that are exported to the cytoplasm for translation and packaging, respectively. The viral Rev protein binds the viral RNA through RRE to permit nuclear export of incompletely spliced RNAs and unspliced genomic RNA. Several nuclear cofactors are believed to take part in this journey from the site of transcription to the nuclear pore. We have previously developed an unbiased proteomic screen to identify proteins that assemble specifically on viral RNA in the context of viral transcription in the nucleus. MATR3, found in this screen, has been already implicated as a cofactor of Rev activity. In this work we extended this observation further providing evidence of the involvement of PSF, another nuclear protein that copurified with viral RNA. Like for MATR3, we did not observe an effect of PSF siRNA-mediated knockdown on transcription. Instead, PSF depletion affected Rev mediated levels of HIV-1 pre-mRNA, which is consistent with a role for PSF in stabilizing pre-mRNA. Differently from MATR3 that affects the ability of Rev to export RNA, PSF seemed to act upstream of MATR3, directly on the RNA pools available for Rev in the nucleus. We further demonstrated that MATR3 and PSF could interact at the protein level and both bound viral RNA, but not directly Rev.
PSF and MATR3 were previously shown to retain A to I hyperedited RNA in the nucleus (Zhang and Carmichael, 2001) . We observed that unspliced HIV-1 RNA was not extensively A to I edited in selected regions for double-stranded RNA that were previously shown to be potential targets for A to I editing like TAR (Sharmeen et al., 1991) or RRE (Phuphuakrat et al., 2008) . Only background modification levels were found at these positions, as also observed by others (Bourara et al., 2000) . Therefore, we could conclude that the activity of MATR3 and PSF on unspliced HIV-1 RNA was independent of RNA hyperediting.
In order to understand at which step of the Rev pathway these factors are involved we explored their sub-nuclear localization with respect to the site of HIV-1 transcription. We found that while PSF associates with the pre-mRNA at site of HIV-1 RNA biogenesis, MATR3 seems to act on viral RNA in the nucleoplasm. Additionally, we explored the localization of the viral Rev protein and we observed that it also bound nascent HIV pre-mRNA at the transcription site. This is an important finding since so far the only indirect demonstration of Rev acting co-transcriptionally comes from early studies on the transactivation potential of Tat-Rev hybrids tethered to TAR-less constructs through association with the RRE (Luo et al., 1993; Southgate et al., 1990) .
We confirmed these finding by biochemical fractionation of the cell to discriminate insoluble from soluble nuclear proteins and proteins associated with chromatin. PSF was found both in the soluble fraction, where it could bind viral RNA and consistent with its localization at the transcription site, and in the nuclear insoluble fraction where it was unable to associate with viral RNA. MATR3 instead, was found predominantly in the nuclear insoluble fraction associated with viral RNA. Rev was detected in the cytoplasm as well as in the nuclear soluble fraction, again consistent with its localization. Unspliced HIV-1 RNA was present mostly in the insoluble nuclear fraction associated with MATR3, in the absence of Rev, and appeared in the soluble and cytoplasmic fraction when Rev was expressed. However, Rev expression did not appear to deplete RNA from the MATR3 associated fraction. Interestingly, Rev function requires continued synthesis of HIV-1 pre-mRNA (Iacampo and Cochrane, 1996) , an observation consistent with the localization of Rev at the transcription site. Therefore, rather than forming a nuclear storage compartment for viral pre-mRNA where Rev would act, as it has been previously proposed (Berthold and Maldarelli, 1996; Najera et al., 1999; Schwartz et al., 1992) , HIV-1 pre-mRNA appears to be associated with Rev at the site of transcription from where it is further exported towards MATR3. The exact role of MATR3 remains elusive. It has been shown that MATR3 is highly proximal to nascent RNA and RNAPII sites but with no direct overlap (Malyavantham et al., 2008) . This led to the proposal that MATR3 is part of 'functional neighborhoods' where genomic functions are concentrated and may potentially be directly involved in the regulation of molecular processes. MATR3 was also copurified with nuclear pore components leading to the hypothesis that it may bridge transcription to export of RNA, possibly in concert with the RNA helicase DDX3X and CRM1. Giving that the provirus was found in proximity to the nuclear periphery it is possible to think a spatially organized perinuclear compartment where nascent viral RNA poised for export by PSF and Rev is transferred to MATR3 for immediate nuclear export.
PSF is a multifunctional RNA binding protein that has been implicated in several steps of the gene expression and DNA repair pathways (Shav-Tal and Zipori, 2002) . PSF interacts with splicing factors and the carboxyterminal domain of RNAPI. It has been shown that PSF controls alternative splicing as well as transcription of several genes including viral transcription in the case of influenza (Landeras-Bueno et al., 2011) . PSF has also been identified as a cellular factor binding RNA of hepatitis delta virus as well as HIV-1 RNA (Greco-Stewart et al., 2006; Kula et al., 2011; Zolotukhin et al., 2003) . PSF can be found in the insoluble fraction of the nucleus, consistent both with its role in the retention of A4 I hyperedited RNA and with its association to non-coding RNAs in paraspeckles. In this work we propose that, in the absence of Rev, PSF binds nascent HIV pre-mRNA at the site of viral transcription, which is then released to MATR3 in the insoluble fraction of the nucleus (Fig. 8A ). This pathway of RREcontaining unspliced viral RNAs maintenance is targeted by the Rev protein. Rev binds the nascent viral pre-mRNA to redirect it to nuclear export through a still poorly characterized mechanism that involves also MATR3 (Kula et al., 2011; Yedavalli and Jeang, 2011a) (Fig. 8B) . In conclusion our current work proposes a highly dynamic interplay between viral and cellular factors that determines the fate of newly transcribed HIV-1 pre-mRNAs. This novel pathway would target a portion of the viral pre-mRNA to a nuclear retention PSF/MATR3 pathway that is hijacked by Rev for nuclear export.
Materials and methods

Cells and plasmids
Cells were cultivated at 37 1C in Dulbecco's Modified Eagle Medium (DMEM) containing 10% FCS and antibiotics. U2OS_ HIVexo and U2OS_HIVintro cells were obtained as described previously Kula et al., 2011) . U2OS_CMV_ 24 Â MS2 were generated by transfecting plasmid CMV_24 Â MS2 (see below) into U2OS cells together with pTK-Hygro and individual clones selected in 132 mg/ml hygromycin.
Plasmids encoding tagged versions of HIV-1 Tat, MATR3 and MS2 were previously described De Marco et al., 2008; Kula et al., 2011; Maiuri et al., 2011b; Marcello et al., 2001) . Plasmid pCMV-Flag-MATR3 was obtained from Yosef Shiloh and Maayan Salton (Tel Aviv University, Israel). Plasmids encoding for GFP-PSF was obtained from Barbara Felber (National Cancer Institute, Frederick, USA). Plasmid Rev-EGFP was obtained from Dirk Daelemans (Rega Institute, Katholieke Universiteit Leuven, Belgium). Plasmid pSV-Rev was obtained from Joseph Sodroski (Dana Farber Cancer Institute, Boston, USA). Plasmid pDM128 was a generous gift from Thomas Hope (Northwestern University, Chicago, USA). The HIV-1 molecular clone pNL4.3R-E-luc was kindly provided by Nathaniel Landau (New York University, USA). Lentiviral vector vHY-IRES-TK was described in (Marcello and Giaretta, 1998) . Plasmid CMV_24 Â MS2 was obtained by cloning an array of 24 Â MS2 binding sites into pCIneo (Promega). U2OS_CMV_24 Â MS2 cells were obtained as described above.
Antibodies, western blot and immunoprecipitations
Western blot and immunofluorescence were performed with the following antibodies: PSF, B92 (Sigma, P2860, 1:1000); MATR3 (Aviva Systems Biology, ARP40922_T100 for immunofluorescence 1:1000; Bethyl Laboratories A300-590A for Western blot 1:10000); p17 (NIH AIDS Reference Reagents Program, 1:1000); MCM3 (N-19) (Santa Cruz, sc-9850 1:500); Lamin A/C (N-18) (Santa Cruz, sc-6215, 1:1000); RNAPII (N-20) (Santa Cruz, sc-899 1:200); phospho-Ser2 RNAPII (H5) (Covance, MMS-129R, 1:500); histone H3 (Upstate, 06-755, 1:300); GFP (Roche, 11814460001, 1:1000); flag (Sigma, F1804, 1:1000); a-tubulin (Sigma, T5168, 1:10000); b-actin -HRP (Sigma, AC-15, 1:10000); PSPC1 (Santa Cruz, sc-374181, for immunofluorescence 1:200).
Immuoprecipitations (IPs) were performed as described previously (Marcello et al., 2003) using the MATR3 antibody (Abcam, 70336), PSF antibody (Abcam, ab99357), and GFP antibody (Clontech, 632376). Briefly, 293 T cells were lysed with RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 0.1% SDS, 1.5 mM MgCl 2 ) and the cellular extracts were incubated for 4 hours with the antibody coupled to A/G PLUS agarose beads (Santa Cruz, sc-2003) at 4 1C under rotation. After incubation of beads with the indicated antibodies, IPs were washed six times in RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 0.1% SDS, 1.5 mM MgCl 2 ) supplemented with 0.1 mg/ml dextran and 0.2 mg/ml heparin. For nuclease treatment, IPs were incubated with 40U of benzonase (Sigma, E1014) for 45 min at 4 1C. After digestion, IPs were washed four times with RIPA buffer and the proteins were eluted with 2x Laemmli buffer for SDS-PAGE.
Immunoprecipitation using the flag antibody was performed as described previously (Kula et al., 2011) . Briefly U2OS stable cells lines were washed in cold PBS and lysed in RIPA buffer (50 mM Tris-Cl; pH 7.5, 1% NP-40, 0.05% SDS, 150 mM NaCl) plus the RNase inhibitor (Ribonucleoside Vanadyl Complex RVC, Biolabs S1402S) and a protease inhibitor cocktail (Roche, 11836170001) . After 15 min at 4 1C the monolayer was scraped off and centrifuged at high speed. Lysates were incubated with anti-flag M2 beads (Sigma, A2220) in the presence of tRNA (0.1 mg/ml) with rotation for 3 hours. The beads were collected at 4000 rpm and were washed six times in RIPA buffer containing 300 mM NaCl. The proteins were eluted with 2x Laemmli buffer for SDS-PAGE.
siRNA-mediated knockdown siRNAs were obtained from Dharmacon: SFPQ siGENOME SmartPool (GAAGAAGCCUUUAGCCAAU,GGCAAAGGAUUCGGAUUUA, GAACAAAUGAGGCGCCAAA, GGGAAAGAGACAUGCGAAU), siGEN-OME Non-Targeting siRNA Pool #1. Pools of siRNA oligonucleotides were introduced into 293T cells or HeLa cells using HiPerFect Transfection Reagent (Qiagen) according to manufacturer's instructions. After 48 h the efficiency of the knockdown was analyzed at the protein level by Western blot.
Nuclear and cytoplasmic fraction preparation, biochemical preparation of insoluble nuclear fraction
Nuclear and cytoplasmic fractions were obtained as described (Kula et al., 2011) . 293T cells were washed with cold PBS and resuspended in hypotonic buffer A: 20 mM Tris HCl [pH 7.5], 10 mM NaCl, 3 mM MgCl2, 10% glycerol and the protease inhibitors cocktail (Roche). After 1 min NP-40 was added at 0.1% v/v final concentration for 5 min and cytoplasmic fraction was collected by centrifugation at 4000 rpm for 5 min at þ4 1C. The pellet was washed with buffer A and the nuclei were collected by centrifugation. Further, the cytoplasmic and nuclear fractions were subjected to RNA extraction procedure.
To isolate the cytoplasmic, nuclear soluble and nuclear insoluble fractions we followed the protocol of He and Penman (He et al., 1990) with minor modifications as outlined in Fig. S2 . Transfected 293T cells were resuspended in CSK buffer: 10 mM PIPES pH 6.8, 10 mM NaCl, 3 mM MgCl 2 , 0.3 M sucrose, 0.5% Triton X-100, 1 mM DTT, 0.1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mM Ribonucleoside-Vanadyl Complex (RVC, Sigma) and protease inhibitors (Roche) and the cells were incubated for 10 min on ice. Nuclei were collected by low-speed centrifugation at 4 1C. The supernatant was further clarified by high-speed centrifugation at 4 1C to remove cell debris and insoluble aggregates (S1). Nuclei were incubated in buffer CSK with protease and RNA inhibitors and 100U of RNase-free DNase I (Fermentas). After 15 min at 37 1C, ammonium sulfate was added from a 4 M stock to a final concentration of 0.25 M. The sample were rotated at 4 1C for 5 min and centrifuged. The supernatant or chromatin fraction (S2) and the pellet (P2) were further collected. All fractions (S1, S2, and P2) were either lysed in 1x Laemmli buffer for Western blot or subjected to RNA extraction.
RT-PCR and qPCR
For RT-PCR and Quantitative Real-Time PCR (qPCR) Analysis the RNA was extracted from total cell extracts, nuclear, or cytoplasmic fractions using Isol-RNA (Invitrogen) according to manufacturer's protocol. RNA was treated with DNase I (Invitrogen) to remove genomic DNA contamination and used as a template to synthesize cDNA using random hexamers and M-MLV reverse transcriptase (Invitrogen) according to the manufacturer's protocol. Endpoint RT PCR (35 cycles, annealing temperature 58 1C) was conducted with primers A þB þC described in Table S1 . Real-time PCR amplification was conducted in the presence of KAPA SYBR FAST Bio-Rad Readymix (KAPA Biosystems) and monitored on C1000 Thermal Cycler (Bio-Rad). Specific primers Aþ B (unspliced) and A þC (spliced) are shown in Table S1 . The viral RNA abundance was calculated relative to the b-actin mRNA expression and shown as fold change in comparison with control samples. Results were expressed as mean plus or minus SD. The two-tailed student-T test confirmed significant expression changes in the results.
Chloramphenicol acetyltransferase (CAT) and luciferase assays 293T cells were transfected with the pDM128 plasmid or HeLa cells with the pNL4.3R-E-luc HIV-1 molecular clone. 24 h later cells were lysed and the levels of CAT or luciferase were measured by the CAT ELISA (Roche) or the luciferase assay (Promega), respectively, as directed by manufacturers. For normalization, total protein concentration in each extract was determined with a Bio-Rad protein assay kit.
Fluorescence microscopy
Cells were plated on glass, transiently transfected with the various plasmids and kept for 24 h at 37 1C. After fixation with 4% paraformaldehyde (PFA) and permeabilization with 0.1% Triton X-100 the localization of fluorescent proteins was visualized directly in mounting medium or incubated with the antibodies as described elsewhere (De Marco et al., 2008 Miorin et al., 2008) . Fluorescent images of fixed cells were captured on a Zeiss LSM 510 META confocal microscope (Carl Zeiss Microimaging, Inc.) with a 63x NA 1.4 Plan-Apochromat oil objective. The pinhole of the microscope was adjusted to get an optical slice of less than 1.0 mm for any wavelength acquired.
